Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
inactivated seasonal influenza vaccine 2008-2009 formulation
- Development stage
- Approved
- Lead developer
- Sinovac Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The inactivated seasonal influenza vaccine 2008-2009 formulation is a pharmaceutical drug designed to prevent seasonal influenza. This specific formulation targeted three influenza virus strains: A/Brisbane/59/2007 (H1N1)-like virus, A/Brisbane/10/2007 (H3N2)-like virus, and B/Florida/4/2006-like virus. The vaccine functions by exposing the immune system to inactivated (killed) viral antigens, primarily hemagglutinin (HA), without causing the disease. This exposure stimulates the body to produce specific antibodies, thereby providing protection against subsequent infection by antigenically similar circulating influenza virus strains. It is typically administered via intramuscular injection.
- Brand names
- AfluriaFluarixFluLavalFluvirinFluzoneAnflu
- Other names
- Trivalent Inactivated Influenza Vaccine
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on inactivated seasonal influenza vaccine 2008-2009 formulation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on inactivated seasonal influenza vaccine 2008-2009 formulation.